Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AUPH - Aurinia Pharmaceuticals: Recent Sell-Off Provides A Great Entry Point

AUPH - Aurinia Pharmaceuticals: Recent Sell-Off Provides A Great Entry Point

Aurinia Pharmaceuticals Inc
  • Lupkynis (voclosporin) received FDA approval in January 2021.
  • Unwarranted sell-off after 1Q21 earnings release has created a buying opportunity.
  • Anticipated solid Lupkynis revenue in 2Q21 and full year 2021.
  • Doubling of share price achievable within 12 months.

For further details see:

Aurinia Pharmaceuticals: Recent Sell-Off Provides A Great Entry Point
Stock Information
Company Name: Aurinia Pharmaceuticals Inc
Stock Symbol: AUPH
Market: NASDAQ
Website: auriniapharma.com
Menu
AUPH AUPH Quote AUPH Short AUPH News AUPH Articles AUPH Message Board
Get AUPH Alerts

News, Short Squeeze, Breakout and More Instantly...